Protect your muscle
En un pronunciamiento conjunto publicado el 11 de agosto del 2023, la American Gastroenterology Association (AGA), la American Association for Study of Liver Disease (AASLD), el American College of Gastroenterology (ACG), la American Society of Gastrointestinal Endoscopy (ASGE) y la North American Society For Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) reconocieron que los agonistas del GLP-1 usados para la diabetes y la prdida de peso pueden alterar el vaciamiento gstrico, y si bien esto puede generar preocupacin sobre la seguridad para realizar procedimientos endoscpicos con sedacin por el riesgo de aspiracin, la asociacin an es anecdtica y el riesgo de gastroparesia se considera dosis dependiente
At the time of study start (July 2023), the only available RCT evidence demonstrated a reduction in alcohol intake in response to GLP-1RAs only in people with obesity, so we focused our study on that population 19
They also face an increased risk of serious and potentially life-threatening health problems
a : T 3 and b : T 4 , c and d : T 3 and T 4 at baseline (day 5) and by end of treatment (day 21), Data are shown as means SEM